Published in Hepatitis Weekly, September 30th, 2002
Janet Vargo and colleagues working with Gen-Probe, Inc. in San Diego, the Chiron Corporation in Emeryville, California, and other nonprofit organizations in Arizona, Florida, Maryland, and Wisconsin evaluated Gen-Probe's Procleix HIV-1/HCV RNA assay.
The Procleix blood screen was fast, sensitive, and specific for its target pathogens, Vargo and coauthors found.
The researchers assessed the sensitivity of the Procleix HIV/HCV assay using more than...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.